Nearly 85% of respondents to an ARUP survey believe the FDA’s proposed rule to regulate lab-developed tests will negatively impact their labs. Only 3% believe they have the financial resources to…
ARUP is committed to continue offering quality, esoteric testing that can aid patients with rare diseases on their often difficult diagnostic journeys.
February is American Heart Month, and ARUP Consult has current resources on testing for acute coronary syndrome, heart failure, and atherosclerotic cardiovascular disease markers.
MetaCensus is the first open-access data repository built for peer-review and meta-analysis. The tool aims to break down stakeholder silos to quickly achieve scientific consensus.
The MenoCheck test helps providers treat women who are experiencing menopausal transition and manage the health risks associated with decreased estrogen production.
ARUP’s new lupus anticoagulant panel neutralizes several interfering anticoagulants to limit their impact on test results and reduce the likelihood of false-negative and false-positive results.
ARUP medical directors and scientists will discuss the latest in pharmacogenomics, RNA sequencing, and laboratory genetics career pathways at the upcoming ACMG Annual Clinical Genetics Meeting.
Researchers at ARUP Laboratories published more than 130 peer-reviewed articles and contributed more than 135 posters or presentations at medical conferences in FY2023 to advance laboratory medicine.